Sanofi
- Country
- 🇫🇷France
- Ownership
- Public
- Employees
- 87.9K
- Market Cap
- $141.3B
- Website
- http://www.sanofi.com
- Introduction
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
Docetaxel and Carboplatin as First-line Chemotherapy in Early Stage as Well as Advanced or Metastatic Ovarian Cancer
- First Posted Date
- 2007-03-28
- Last Posted Date
- 2012-08-14
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 30
- Registration Number
- NCT00452985
- Locations
- 🇧🇩
Sanofi-Aventis, Dhaka, Bangladesh
ACT MALI: Treatment of Malaria Based on Combination Therapies
- Conditions
- Malaria
- Interventions
- First Posted Date
- 2007-03-28
- Last Posted Date
- 2010-02-17
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 780
- Registration Number
- NCT00452907
- Locations
- 🇲🇱
Sanofi-Aventis Administrative Office, Bougoula, Mali
Effect of MAXOMAT ® on the Growth of Small Children to NOONAN's Syndrome
- Conditions
- Noonan Syndrome
- First Posted Date
- 2007-03-27
- Last Posted Date
- 2010-10-05
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 36
- Registration Number
- NCT00452725
- Locations
- 🇫🇷
Sanofi-Aventis, Paris, France
MAXOMAT ® in the Treatment of Severe Early Onset Intrauterine Growth Retardation on Pre-pubertal Children
- First Posted Date
- 2007-03-27
- Last Posted Date
- 2010-10-05
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 306
- Registration Number
- NCT00452491
- Locations
- 🇫🇷
Sanofi-Aventis, Paris, France
Objective Study in Rheumatoid Arthritis
- Conditions
- Arthritis, Rheumatoid
- First Posted Date
- 2007-03-26
- Last Posted Date
- 2008-09-05
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 249
- Registration Number
- NCT00451971
- Locations
- 🇦🇺
Sanofi-Aventis, Sydney, Australia
Open Label, Phase I ZD6474 Head and Neck Cancer Study
- Conditions
- Head and Neck Cancer
- Interventions
- First Posted Date
- 2007-03-21
- Last Posted Date
- 2016-08-29
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 48
- Registration Number
- NCT00450138
- Locations
- 🇺🇸
Research Site, Houston, Texas, United States
A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2007-03-20
- Last Posted Date
- 2016-05-16
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 508
- Registration Number
- NCT00449605
- Locations
- 🇨🇱
Sanofi-aventis adminsitrative office, Santiago, Chile
🇸🇪Sanofi-Aventis Administrative Office, Bromma, Sweden
Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR)
- Conditions
- Rhinitis, Allergic, Perennial
- Interventions
- First Posted Date
- 2007-03-19
- Last Posted Date
- 2012-08-10
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 299
- Registration Number
- NCT00449072
- Locations
- 🇺🇸
Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, United States
Preventing Antibiotic-Associated DiarRhea Using Erceflora
- Conditions
- Diarrhea, Infantile
- Interventions
- Drug: Bacillus Clausii Multi ATB ResistDrug: Placebo
- First Posted Date
- 2007-03-14
- Last Posted Date
- 2008-09-05
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 323
- Registration Number
- NCT00447161
- Locations
- 🇵🇭
Sanofi-Aventis, Manila, Philippines
Pilot Study of the Safety & Efficacy of Two Docetaxel-Based Regimens Plus Bevacizumab for the Adjuvant Treatment of Subjects With Node Positive or High Risk Node Negative Breast Cancer
- Conditions
- Breast Neoplasms
- Interventions
- First Posted Date
- 2007-03-12
- Last Posted Date
- 2012-06-26
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 127
- Registration Number
- NCT00446030
- Locations
- 🇺🇸
Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, United States